Linked inTwitterFacebookSubscribe to Halcyon Headlines Feed

Part consultancy, part thinktank, part social enterprise, Halcyon helps you prepare for and respond to personal, organisational and societal change.

See Halcyon's unique reporting on the United Nations Sustainable Development Goals and contact us to discuss how we may be able to help you contribute to and/or create value from the SDGs.

Follow Halcyon's forthcoming 52:52:52 campaign on Twitter, which will feature 52 issues and 52 responses over 52 weeks.

CRISPR

On CRISPR

Genetics

 

40%: The percentage of patients reported to have responded to one of the most advanced CRISPR cancer therapy studies to be tested in China. China is far ahead of the US in CRISPR cancer studies due to its less stringent approval requirements, but the US and Europe are set to see their first human trials of the gene-editing technique this year. With potentially transformative implications across medicine, agriculture, and even chemical products, CB Insights' 5,200-word CRISPR deep dive unpacks the science behind the technology, its applications, controversies it’s stirred up, and where CRISPR may take us next.